Efficient utilization of complex N-linked glycans is a selective advantage for Bacteroides fragilis in extraintestinal infections

Significance Human microbiota have a huge impact on health from proper development of the immune system to maintenance of normal physiological processes. The largest concentration of microbes is found in the colon, which is home to hundreds of bacterial species, most of which are obligate anaerobes. This population also poses a significant threat of opportunistic infection, and of all the species present, Bacteroides fragilis is the anaerobe most frequently isolated from extraintestinal infections of intestinal origin. The findings presented here describe a unique ability of this species to efficiently deglycosylate complex N-linked glycans from the most abundant glycoproteins found in serum and serous fluid, which gives B. fragilis a competitive, nutritional advantage for extraintestinal growth. Bacteroides fragilis is the most common anaerobe isolated from clinical infections, and in this report we demonstrate a characteristic of the species that is critical to their success as an opportunistic pathogen. Among the Bacteroides spp. in the gut, B. fragilis has the unique ability of efficiently harvesting complex N-linked glycans from the glycoproteins common to serum and serous fluid. This activity is mediated by an outer membrane protein complex designated as Don. Using the abundant serum glycoprotein transferrin as a model, it has been shown that B. fragilis alone can rapidly and efficiently deglycosylate this protein in vitro and that transferrin glycans can provide the sole source of carbon and energy for growth in defined media. We then showed that transferrin deglycosylation occurs in vivo when B. fragilis is propagated in the rat tissue cage model of extraintestinal growth, and that this ability provides a competitive advantage in vivo over strains lacking the don locus.

[1]  E. Martens,et al.  Dynamic responses of Bacteroides thetaiotaomicron during growth on glycan mixtures , 2013, Molecular microbiology.

[2]  J. Clemente,et al.  The Long-Term Stability of the Human Gut Microbiota , 2013 .

[3]  E. R. Rocha,et al.  Regulation of Bacteriodes fragilis katB mRNA by oxidative stress and carbon limitation , 1997, Journal of bacteriology.

[4]  A. Rowan Guide for the Care and Use of Laboratory Animals , 1979 .

[5]  Eric C. Martens,et al.  Complex Glycan Catabolism by the Human Gut Microbiota: The Bacteroidetes Sus-like Paradigm , 2009, The Journal of Biological Chemistry.

[6]  E. Martens,et al.  How glycan metabolism shapes the human gut microbiota , 2012, Nature Reviews Microbiology.

[7]  J. Rosenblatt,et al.  Reemergence of anaerobic bacteremia. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  G. Cornelis,et al.  The N-glycan Glycoprotein Deglycosylation Complex (Gpd) from Capnocytophaga canimorsus Deglycosylates Human IgG , 2011, PLoS pathogens.

[9]  I. Brook Recovery of anaerobic bacteria from clinical specimens in 12 years at two military hospitals , 1988, Journal of clinical microbiology.

[10]  C. Biggers,et al.  Bacteriostatic inhibition of Klebsiella pneumoniae by three human transferrins. , 1977, Annals of Human Biology.

[11]  L. Lobo,et al.  Expression of Bacteroides fragilis hemolysins in vivo and role of HlyBA in an intra-abdominal infection model , 2013, MicrobiologyOpen.

[12]  C. Enns,et al.  N-Linked Glycosylation Is Required for Transferrin-Induced Stabilization of Transferrin Receptor 2, but Not for Transferrin Binding or Trafficking to the Cell Surface , 2013, Biochemistry.

[13]  J. Jensenius,et al.  EndoS and SpeB from Streptococcus pyogenes Inhibit Immunoglobulin-Mediated Opsonophagocytosis , 2002, Infection and Immunity.

[14]  J. Weiser,et al.  Deglycosylation of human glycoconjugates by the sequential activities of exoglycosidases expressed by Streptococcus pneumoniae , 2006, Molecular microbiology.

[15]  W. D. de Vos,et al.  Mucin-bacterial interactions in the human oral cavity and digestive tract , 2010, Gut microbes.

[16]  Laurie E. Comstock,et al.  Extensive surface diversity of a commensal microorganism by multiple DNA inversions , 2001, Nature.

[17]  S. King,et al.  Growth of Streptococcus pneumoniae on Human Glycoconjugates Is Dependent upon the Sequential Activity of Bacterial Exoglycosidases , 2007, Journal of bacteriology.

[18]  J. Gordon,et al.  Mucosal glycan foraging enhances fitness and transmission of a saccharolytic human gut bacterial symbiont. , 2008, Cell host & microbe.

[19]  B. Polk,et al.  Bacteroides fragilis subspecies in clinical isolates. , 1977, Annals of internal medicine.

[20]  M. Nakano,et al.  Comprehensive approach to structural and functional glycomics based on chemoselective glycoblotting and sequential tag conversion. , 2008, Analytical chemistry.

[21]  E. Purdom,et al.  Diversity of the Human Intestinal Microbial Flora , 2005, Science.

[22]  M. Malamy,et al.  A role for Bacteroides fragilis neuraminidase in bacterial growth in two model systems , 1993, Infection and Immunity.

[23]  M. Malamy,et al.  Sialic Acid (N-Acetyl Neuraminic Acid) Utilization by Bacteroides fragilis Requires a Novel N-Acetyl Mannosamine Epimerase , 2009, Journal of bacteriology.

[24]  E. Theunissen,et al.  Epidemiology of the Bacteroides fragilis group in the colonic flora in 10 patients with colonic cancer. , 1989, Journal of medical microbiology.

[25]  Klaus Ley,et al.  Bacterial colonization factors control specificity and stability of the gut microbiota , 2013, Nature.

[26]  M. Finland,et al.  Enhancement of Acute Bacterial Infections in Rats and Mice by Iron and Their Inhibition by Human Transferrin , 1963 .

[27]  D. Bamberger,et al.  Effects of Neutrophils on Cefazolin Activity and Penicillin-Binding Proteins in Staphylococcus aureus Abscesses , 2002, Antimicrobial Agents and Chemotherapy.

[28]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[29]  A. Olsén,et al.  EndoS, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG , 2001, The EMBO journal.

[30]  Hiroaki Nakagawa,et al.  High-throughput protein glycomics: combined use of chemoselective glycoblotting and MALDI-TOF/TOF mass spectrometry. , 2004, Angewandte Chemie.

[31]  M. P. Bryant,et al.  Nutritional features of Bacteroides fragilis subsp. fragilis. , 1974, Applied microbiology.

[32]  Jason M Gee,et al.  The Bacteroides fragilis transcriptome response to oxygen and H2O2: the role of OxyR and its effect on survival and virulence , 2007, Molecular microbiology.

[33]  Jason M Gee,et al.  The Extracytoplasmic Function Sigma Factor EcfO Protects Bacteroides fragilis against Oxidative Stress , 2012, Journal of bacteriology.

[34]  T. Kuwahara,et al.  Characterization of a gene cluster for sialoglycoconjugate utilization in Bacteroides fragilis. , 2012, The journal of medical investigation : JMI.